COV001 clinical trial results : Oxford vaccine ChAdOx1 nCoV-19 triggers strong immune response

pharmanewsdaily- July 20, 2020 0

COV001 clinical trial results : AstraZeneca and Oxford University said that interim results from the phase 1/2 COV001 clinical trial showed the ChAdOx1 nCoV-19 vaccine ... Read More